Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...

These resources include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, ...

The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...

The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...

The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been ...

Patients with fibromyalgia experienced changes in the macular ganglion cell layer and retinal nerve fiber layer.

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in subjects with GA ...

The multinational, multicenter, prospective RESTORE Study is the 5-year follow-up study of the phase 3 clinical RESCUE and ...

The Danish Medicines Agency requested the EMA's Pharmacovigilance Risk Assessment Committee review reports on the ...

Lana Rifkin, MD, a uveitis specialist at Ophthalmic Consultants of Boston, shared insights into her work and her role as ...